Open AccessThe difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers
Author(s) -
Hayato Kaida,
Akihiko Kawahara,
Masanobu Hayakawa,
Satoshi Hattori,
Seiji Kurata,
Kiminori Fujimoto,
Koichi Azuma,
Yasumitsu Hirose,
Shinzo Takamori,
Yuji Hiromatsu,
Tadashi Nakashima,
Hiromasa Fujita,
Masayoshi Kage,
Naofumi Hayabuchi,
Masatoshi Ishibashi
Publication year - 2014
Publication title -
nuclear medicine communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.489
H-Index - 73
eISSN - 1473-5628
pISSN - 0143-3636
DOI - 10.1097/mnm.0000000000000019
Subject(s) - medicine , standardized uptake value , lung cancer , pathological , t stage , stage (stratigraphy) , oncology , carcinoma , thyroid carcinoma , spearman's rank correlation coefficient , thyroid cancer , lymph node , esophageal squamous cell carcinoma , thyroid , cancer , gastroenterology , positron emission tomography , nuclear medicine , biology , paleontology , statistics , mathematics
The aim of this study was to reveal the differences in clinicopathological factors affecting maximum standardized uptake value (SUVmax) between esophageal squamous cell carcinoma (ESCC), non-small-cell lung cancer (NSCLC), and papillary thyroid cancer (PTC).